Today's Daily Dose brings you news about the effectiveness of Lilly's Bamlanivimab in reducing the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, executive changes at BiondVax Pharma, regulatory update on Genetic Technologies' COVID-19 PRS Test, Adamis' SYMJEPI products being made available in the Walgreens Prescription Savings Club, to name a few.